AU2002218342A1 - Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer - Google Patents
Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancerInfo
- Publication number
- AU2002218342A1 AU2002218342A1 AU2002218342A AU1834202A AU2002218342A1 AU 2002218342 A1 AU2002218342 A1 AU 2002218342A1 AU 2002218342 A AU2002218342 A AU 2002218342A AU 1834202 A AU1834202 A AU 1834202A AU 2002218342 A1 AU2002218342 A1 AU 2002218342A1
- Authority
- AU
- Australia
- Prior art keywords
- esm
- medicine
- protein
- producing
- treating cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0014422 | 2000-11-09 | ||
FR0014422A FR2816214B1 (fr) | 2000-11-09 | 2000-11-09 | Utilisation d'un compose antagoniste de la proteine esm-1 pour la fabrication d'un medicament pour la prevention et/ou le traitement d'un cancer |
PCT/FR2001/003475 WO2002038178A1 (fr) | 2000-11-09 | 2001-11-08 | Utilisation d'un compose antagoniste de la proteine esm-1 pour la fabrication d'un medicament pour le traitement d'un cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002218342A1 true AU2002218342A1 (en) | 2002-05-21 |
Family
ID=8856265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002218342A Abandoned AU2002218342A1 (en) | 2000-11-09 | 2001-11-08 | Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
Country Status (7)
Country | Link |
---|---|
US (1) | US7306797B2 (fr) |
EP (1) | EP1335745A1 (fr) |
JP (1) | JP4121852B2 (fr) |
AU (1) | AU2002218342A1 (fr) |
CA (1) | CA2429404A1 (fr) |
FR (1) | FR2816214B1 (fr) |
WO (1) | WO2002038178A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006506966A (ja) * | 2002-07-01 | 2006-03-02 | ファルマシア・コーポレーション | 血管新生において差次的に発現するesm−1遺伝子、そのアンタゴニスト、および、それらを使用する方法 |
US20070197452A1 (en) * | 2006-02-17 | 2007-08-23 | Mclaurin Joanne | Treatment of amyloid-related diseases |
US20110301092A1 (en) * | 2007-10-24 | 2011-12-08 | Institut Pasteur De Lille | The use of a non-glycanated polypeptide for treating a cancer |
TWI772927B (zh) * | 2015-03-31 | 2022-08-01 | 德商英麥提克生物技術股份有限公司 | 用於腎細胞癌(rcc)免疫治療的新型肽和肽組合物和支架 |
GB201505585D0 (en) | 2015-03-31 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747280A (en) * | 1995-06-05 | 1998-05-05 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
EP0796325A4 (fr) * | 1994-12-09 | 1999-11-03 | Human Genome Sciences Inc | Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide |
US6670328B1 (en) | 1997-06-24 | 2003-12-30 | Institut Pasteur De Lille | Proteins and peptides derived from protein ESM-1 and their uses in the treatment and diagnosis of diseases linked to leukocyte migration |
FR2775691B1 (fr) * | 1998-03-05 | 2000-12-15 | Pasteur Institut | Anticorps monoclonaux specifiques de la proteine esm-1, et utilisation de ces anticorps pour la detection de la proteine esm-1 |
-
2000
- 2000-11-09 FR FR0014422A patent/FR2816214B1/fr not_active Expired - Fee Related
-
2001
- 2001-11-08 EP EP01993475A patent/EP1335745A1/fr not_active Withdrawn
- 2001-11-08 AU AU2002218342A patent/AU2002218342A1/en not_active Abandoned
- 2001-11-08 JP JP2002540760A patent/JP4121852B2/ja not_active Expired - Fee Related
- 2001-11-08 WO PCT/FR2001/003475 patent/WO2002038178A1/fr active Application Filing
- 2001-11-08 US US10/416,203 patent/US7306797B2/en not_active Expired - Fee Related
- 2001-11-08 CA CA002429404A patent/CA2429404A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002038178A1 (fr) | 2002-05-16 |
FR2816214B1 (fr) | 2005-10-21 |
JP4121852B2 (ja) | 2008-07-23 |
US20040234526A1 (en) | 2004-11-25 |
CA2429404A1 (fr) | 2002-05-06 |
FR2816214A1 (fr) | 2002-05-10 |
JP2004518638A (ja) | 2004-06-24 |
US7306797B2 (en) | 2007-12-11 |
EP1335745A1 (fr) | 2003-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7031500A (en) | Therapeutic quinazoline compounds | |
AU2002221239A1 (en) | Therapeutic benzimidazole compounds | |
AU2002213848A1 (en) | Integrated process for the preparation of olefin oxides | |
HK1080361A1 (en) | The use of compound in the preparation of medicaments for treating demyelinating diseases | |
AU2001284021A1 (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2002343739A1 (en) | Improved therapy for topical diseases | |
AU2003224076A1 (en) | Antibody combination useful for tumor therapy | |
AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
AU2000258650A1 (en) | 2-piperidone compounds for the treatment of cancer | |
AU2002354410A1 (en) | Triazole compound and medicinal use thereof | |
AU2001267831A1 (en) | DDS compound and process for the preparation thereof | |
AU2002217866A1 (en) | Geldanamycin derivatives useful for the treatment of cancer | |
AU2002353739A1 (en) | Therapeutic compounds | |
AU2002218342A1 (en) | Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer | |
AU2002358469A1 (en) | Modified receptors for the discovery of therapeutic ligands | |
AU2002218750A1 (en) | Photoactivated drug therapy | |
AU2001254712A1 (en) | Use of organophosphorous compounds for producing a medicament for treating infections | |
AU4450100A (en) | 225Ac-heha and related compounds, methods of synthesis and methods of use | |
AU2001287884A1 (en) | Halogen compounds for use in medicine | |
AU2001289127A1 (en) | Tumor treatment | |
AU2002212582A1 (en) | Process for preparing (-)- menthol and similar compounds | |
AU2002348105A1 (en) | Oral dosage forms for improving the bioavailability of therapeutic agents | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU2001271261A1 (en) | Therapeutic treatment of cancer with a protein kinase c inhibitor | |
AU2002232563A1 (en) | Compounds for therapy and diagnosis and methods for using same |